List of Tables
Table 1. Global Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of AAV
Table 3. Key Players of Lentivirus
Table 4. Key Players of Adenovirus
Table 5. Key Players of HSV
Table 6. Key Players of Others
Table 7. Global Viral Vector Manufacturing for Gene Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Viral Vector Manufacturing for Gene Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 9. Global Viral Vector Manufacturing for Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 10. Global Viral Vector Manufacturing for Gene Therapy Market Share by Region (2019-2024)
Table 11. Global Viral Vector Manufacturing for Gene Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 12. Global Viral Vector Manufacturing for Gene Therapy Market Share by Region (2025-2030)
Table 13. Viral Vector Manufacturing for Gene Therapy Market Trends
Table 14. Viral Vector Manufacturing for Gene Therapy Market Drivers
Table 15. Viral Vector Manufacturing for Gene Therapy Market Challenges
Table 16. Viral Vector Manufacturing for Gene Therapy Market Restraints
Table 17. Global Viral Vector Manufacturing for Gene Therapy Revenue by Players (2019-2024) & (US$ Million)
Table 18. Global Viral Vector Manufacturing for Gene Therapy Market Share by Players (2019-2024)
Table 19. Global Top Viral Vector Manufacturing for Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing for Gene Therapy as of 2023)
Table 20. Ranking of Global Top Viral Vector Manufacturing for Gene Therapy Companies by Revenue (US$ Million) in 2023
Table 21. Global 5 Largest Players Market Share by Viral Vector Manufacturing for Gene Therapy Revenue (CR5 and HHI) & (2019-2024)
Table 22. Global Key Players of Viral Vector Manufacturing for Gene Therapy, Headquarters and Area Served
Table 23. Global Key Players of Viral Vector Manufacturing for Gene Therapy, Product and Application
Table 24. Global Key Players of Viral Vector Manufacturing for Gene Therapy, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Viral Vector Manufacturing for Gene Therapy Market Size by Type (2019-2024) & (US$ Million)
Table 27. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Type (2019-2024)
Table 28. Global Viral Vector Manufacturing for Gene Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 29. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Type (2025-2030)
Table 30. Global Viral Vector Manufacturing for Gene Therapy Market Size by Application (2019-2024) & (US$ Million)
Table 31. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Application (2019-2024)
Table 32. Global Viral Vector Manufacturing for Gene Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 33. Global Viral Vector Manufacturing for Gene Therapy Revenue Market Share by Application (2025-2030)
Table 34. North America Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. North America Viral Vector Manufacturing for Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 36. North America Viral Vector Manufacturing for Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 37. Europe Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Europe Viral Vector Manufacturing for Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 39. Europe Viral Vector Manufacturing for Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 40. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 42. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 43. Latin America Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Latin America Viral Vector Manufacturing for Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 45. Latin America Viral Vector Manufacturing for Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 46. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 47. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size by Country (2019-2024) & (US$ Million)
Table 48. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size by Country (2025-2030) & (US$ Million)
Table 49. Thermo Fisher Scientific Company Details
Table 50. Thermo Fisher Scientific Business Overview
Table 51. Thermo Fisher Scientific Viral Vector Manufacturing for Gene Therapy Product
Table 52. Thermo Fisher Scientific Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 53. Thermo Fisher Scientific Recent Development
Table 54. Lonza Company Details
Table 55. Lonza Business Overview
Table 56. Lonza Viral Vector Manufacturing for Gene Therapy Product
Table 57. Lonza Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 58. Lonza Recent Development
Table 59. Catalent Company Details
Table 60. Catalent Business Overview
Table 61. Catalent Viral Vector Manufacturing for Gene Therapy Product
Table 62. Catalent Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 63. Catalent Recent Development
Table 64. Charles River Company Details
Table 65. Charles River Business Overview
Table 66. Charles River Viral Vector Manufacturing for Gene Therapy Product
Table 67. Charles River Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 68. Charles River Recent Development
Table 69. Merck Company Details
Table 70. Merck Business Overview
Table 71. Merck Viral Vector Manufacturing for Gene Therapy Product
Table 72. Merck Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 73. Merck Recent Development
Table 74. SK pharmteco Company Details
Table 75. SK pharmteco Business Overview
Table 76. SK pharmteco Viral Vector Manufacturing for Gene Therapy Product
Table 77. SK pharmteco Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 78. SK pharmteco Recent Development
Table 79. Oxford Biomedica Company Details
Table 80. Oxford Biomedica Business Overview
Table 81. Oxford Biomedica Viral Vector Manufacturing for Gene Therapy Product
Table 82. Oxford Biomedica Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 83. Oxford Biomedica Recent Development
Table 84. AGC Biologics（MolMed） Company Details
Table 85. AGC Biologics（MolMed） Business Overview
Table 86. AGC Biologics（MolMed） Viral Vector Manufacturing for Gene Therapy Product
Table 87. AGC Biologics（MolMed） Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 88. AGC Biologics（MolMed） Recent Development
Table 89. Gene Universal Company Details
Table 90. Gene Universal Business Overview
Table 91. Gene Universal Viral Vector Manufacturing for Gene Therapy Product
Table 92. Gene Universal Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 93. Gene Universal Recent Development
Table 94. Polyplus (Sartorius) Company Details
Table 95. Polyplus (Sartorius) Business Overview
Table 96. Polyplus (Sartorius) Viral Vector Manufacturing for Gene Therapy Product
Table 97. Polyplus (Sartorius) Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 98. Polyplus (Sartorius) Recent Development
Table 99. CCRM Company Details
Table 100. CCRM Business Overview
Table 101. CCRM Viral Vector Manufacturing for Gene Therapy Product
Table 102. CCRM Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 103. CCRM Recent Development
Table 104. FUJIFILM Diosynth Biotechnologies Company Details
Table 105. FUJIFILM Diosynth Biotechnologies Business Overview
Table 106. FUJIFILM Diosynth Biotechnologies Viral Vector Manufacturing for Gene Therapy Product
Table 107. FUJIFILM Diosynth Biotechnologies Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 108. FUJIFILM Diosynth Biotechnologies Recent Development
Table 109. Biovian Company Details
Table 110. Biovian Business Overview
Table 111. Biovian Viral Vector Manufacturing for Gene Therapy Product
Table 112. Biovian Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 113. Biovian Recent Development
Table 114. Miltenyi Bioindustry Company Details
Table 115. Miltenyi Bioindustry Business Overview
Table 116. Miltenyi Bioindustry Viral Vector Manufacturing for Gene Therapy Product
Table 117. Miltenyi Bioindustry Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 118. Miltenyi Bioindustry Recent Development
Table 119. Aldevron Company Details
Table 120. Aldevron Business Overview
Table 121. Aldevron Viral Vector Manufacturing for Gene Therapy Product
Table 122. Aldevron Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 123. Aldevron Recent Development
Table 124. Takara Bio Company Details
Table 125. Takara Bio Business Overview
Table 126. Takara Bio Viral Vector Manufacturing for Gene Therapy Product
Table 127. Takara Bio Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 128. Takara Bio Recent Development
Table 129. Yposkesi Company Details
Table 130. Yposkesi Business Overview
Table 131. Yposkesi Viral Vector Manufacturing for Gene Therapy Product
Table 132. Yposkesi Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 133. Yposkesi Recent Development
Table 134. Genezen Company Details
Table 135. Genezen Business Overview
Table 136. Genezen Viral Vector Manufacturing for Gene Therapy Product
Table 137. Genezen Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 138. Genezen Recent Development
Table 139. Exthera Company Details
Table 140. Exthera Business Overview
Table 141. Exthera Viral Vector Manufacturing for Gene Therapy Product
Table 142. Exthera Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 143. Exthera Recent Development
Table 144. Flash Therapeutics Company Details
Table 145. Flash Therapeutics Business Overview
Table 146. Flash Therapeutics Viral Vector Manufacturing for Gene Therapy Product
Table 147. Flash Therapeutics Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 148. Flash Therapeutics Recent Development
Table 149. VIVEBiotech Company Details
Table 150. VIVEBiotech Business Overview
Table 151. VIVEBiotech Viral Vector Manufacturing for Gene Therapy Product
Table 152. VIVEBiotech Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 153. VIVEBiotech Recent Development
Table 154. FinVector Company Details
Table 155. FinVector Business Overview
Table 156. FinVector Viral Vector Manufacturing for Gene Therapy Product
Table 157. FinVector Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 158. FinVector Recent Development
Table 159. Eurogentec Company Details
Table 160. Eurogentec Business Overview
Table 161. Eurogentec Viral Vector Manufacturing for Gene Therapy Product
Table 162. Eurogentec Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 163. Eurogentec Recent Development
Table 164. VGXI Company Details
Table 165. VGXI Business Overview
Table 166. VGXI Viral Vector Manufacturing for Gene Therapy Product
Table 167. VGXI Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 168. VGXI Recent Development
Table 169. GenScript ProBio Company Details
Table 170. GenScript ProBio Business Overview
Table 171. GenScript ProBio Viral Vector Manufacturing for Gene Therapy Product
Table 172. GenScript ProBio Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 173. GenScript ProBio Recent Development
Table 174. EurekaBio Company Details
Table 175. EurekaBio Business Overview
Table 176. EurekaBio Viral Vector Manufacturing for Gene Therapy Product
Table 177. EurekaBio Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 178. EurekaBio Recent Development
Table 179. Obio Technology Company Details
Table 180. Obio Technology Business Overview
Table 181. Obio Technology Viral Vector Manufacturing for Gene Therapy Product
Table 182. Obio Technology Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 183. Obio Technology Recent Development
Table 184. GeneSail Biotech Company Details
Table 185. GeneSail Biotech Business Overview
Table 186. GeneSail Biotech Viral Vector Manufacturing for Gene Therapy Product
Table 187. GeneSail Biotech Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 188. GeneSail Biotech Recent Development
Table 189. VectorBuilder Company Details
Table 190. VectorBuilder Business Overview
Table 191. VectorBuilder Viral Vector Manufacturing for Gene Therapy Product
Table 192. VectorBuilder Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 193. VectorBuilder Recent Development
Table 194. WuXi ATU Company Details
Table 195. WuXi ATU Business Overview
Table 196. WuXi ATU Viral Vector Manufacturing for Gene Therapy Product
Table 197. WuXi ATU Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 198. WuXi ATU Recent Development
Table 199. Ubrigene Company Details
Table 200. Ubrigene Business Overview
Table 201. Ubrigene Viral Vector Manufacturing for Gene Therapy Product
Table 202. Ubrigene Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 203. Ubrigene Recent Development
Table 204. Porton Biologics Company Details
Table 205. Porton Biologics Business Overview
Table 206. Porton Biologics Viral Vector Manufacturing for Gene Therapy Product
Table 207. Porton Biologics Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 208. Porton Biologics Recent Development
Table 209. Pharmaron Company Details
Table 210. Pharmaron Business Overview
Table 211. Pharmaron Viral Vector Manufacturing for Gene Therapy Product
Table 212. Pharmaron Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 213. Pharmaron Recent Development
Table 214. PackGene Biotechnology Company Details
Table 215. PackGene Biotechnology Business Overview
Table 216. PackGene Biotechnology Viral Vector Manufacturing for Gene Therapy Product
Table 217. PackGene Biotechnology Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 218. PackGene Biotechnology Recent Development
Table 219. Hillgene Company Details
Table 220. Hillgene Business Overview
Table 221. Hillgene Viral Vector Manufacturing for Gene Therapy Product
Table 222. Hillgene Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 223. Hillgene Recent Development
Table 224. Asymchem Company Details
Table 225. Asymchem Business Overview
Table 226. Asymchem Viral Vector Manufacturing for Gene Therapy Product
Table 227. Asymchem Revenue in Viral Vector Manufacturing for Gene Therapy Business (2019-2024) & (US$ Million)
Table 228. Asymchem Recent Development
Table 229. Research Programs/Design for This Report
Table 230. Key Data Information from Secondary Sources
Table 231. Key Data Information from Primary Sources
Table 232. Authors List of This Report
List of Figures
Figure 1. Viral Vector Manufacturing for Gene Therapy Picture
Figure 2. Global Viral Vector Manufacturing for Gene Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Viral Vector Manufacturing for Gene Therapy Market Share by Type: 2023 VS 2030
Figure 4. AAV Features
Figure 5. Lentivirus Features
Figure 6. Adenovirus Features
Figure 7. HSV Features
Figure 8. Others Features
Figure 9. Global Viral Vector Manufacturing for Gene Therapy Market Size by Application (2024-2030) & (US$ Million)
Figure 10. Global Viral Vector Manufacturing for Gene Therapy Market Share by Application: 2023 VS 2030
Figure 11. Vaccine Development Case Studies
Figure 12. Gene Therapy Case Studies
Figure 13. Academic Scientific Research Institution Case Studies
Figure 14. Others Case Studies
Figure 15. Viral Vector Manufacturing for Gene Therapy Report Years Considered
Figure 16. Global Viral Vector Manufacturing for Gene Therapy Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 17. Global Viral Vector Manufacturing for Gene Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 18. Global Viral Vector Manufacturing for Gene Therapy Market Share by Region: 2023 VS 2030
Figure 19. Global Viral Vector Manufacturing for Gene Therapy Market Share by Players in 2023
Figure 20. Global Top Viral Vector Manufacturing for Gene Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Viral Vector Manufacturing for Gene Therapy as of 2023)
Figure 21. The Top 10 and 5 Players Market Share by Viral Vector Manufacturing for Gene Therapy Revenue in 2023
Figure 22. North America Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Viral Vector Manufacturing for Gene Therapy Market Share by Country (2019-2030)
Figure 24. United States Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Canada Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Europe Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Europe Viral Vector Manufacturing for Gene Therapy Market Share by Country (2019-2030)
Figure 28. Germany Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. France Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. U.K. Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Italy Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Russia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Nordic Countries Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Asia-Pacific Viral Vector Manufacturing for Gene Therapy Market Share by Region (2019-2030)
Figure 36. China Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Japan Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. South Korea Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Southeast Asia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. India Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Australia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Latin America Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Latin America Viral Vector Manufacturing for Gene Therapy Market Share by Country (2019-2030)
Figure 44. Mexico Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Brazil Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Middle East & Africa Viral Vector Manufacturing for Gene Therapy Market Share by Country (2019-2030)
Figure 48. Turkey Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 50. UAE Viral Vector Manufacturing for Gene Therapy Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 52. Lonza Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 53. Catalent Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 54. Charles River Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 55. Merck Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 56. SK pharmteco Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 57. Oxford Biomedica Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 58. AGC Biologics（MolMed） Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 59. Gene Universal Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 60. Polyplus (Sartorius) Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 61. CCRM Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 62. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 63. Biovian Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 64. Miltenyi Bioindustry Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 65. Aldevron Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 66. Takara Bio Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 67. Yposkesi Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 68. Genezen Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 69. Exthera Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 70. Flash Therapeutics Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 71. VIVEBiotech Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 72. FinVector Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 73. Eurogentec Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 74. VGXI Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 75. GenScript ProBio Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 76. EurekaBio Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 77. Obio Technology Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 78. GeneSail Biotech Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 79. VectorBuilder Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 80. WuXi ATU Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 81. Ubrigene Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 82. Porton Biologics Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 83. Pharmaron Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 84. PackGene Biotechnology Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 85. Hillgene Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 86. Asymchem Revenue Growth Rate in Viral Vector Manufacturing for Gene Therapy Business (2019-2024)
Figure 87. Bottom-up and Top-down Approaches for This Report
Figure 88. Data Triangulation
Figure 89. Key Executives Interviewed
